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Abstract
4-Hydroxynonenal (4-HNE) is a reactive a,b-unsaturated aldehyde produced during oxidative stress and subsequent lipid
peroxidation of polyunsaturated fatty acids. The reactivity of 4-HNE towards DNA and nucleophilic amino acids has been
well established. In this report, using proteomic approaches, liver fatty acid-binding protein (L-FABP) is identified as a target
for modification by 4-HNE. This lipid binding protein mediates the uptake and trafficking of hydrophobic ligands
throughout cellular compartments. Ethanol caused a significant decrease in L-FABP protein (P,0.001) and mRNA (P,0.05),
as well as increased poly-ubiquitinated L-FABP (P,0.001). Sites of 4-HNE adduction on mouse recombinant L-FABP were
mapped using MALDI-TOF/TOF mass spectrometry on apo (Lys57 and Cys69) and holo (Lys6, Lys31, His43, Lys46, Lys57 and
Cys69) L-FABP. The impact of 4-HNE adduction was found to occur in a concentration-dependent manner; affinity for the
fluorescent ligand, anilinonaphthalene-8-sulfonic acid, was reduced from 0.347 mMt oK d 1=0.395 mM and Kd2=34.20 mM.
Saturation analyses revealed that capacity for ligand is reduced by approximately 50% when adducted by 4-HNE. Thermal
stability curves of apo L-FABP was also found to be significantly affected by 4-HNE adduction (DTm=5.44uC, P,0.01).
Computational-based molecular modeling simulations of adducted protein revealed minor conformational changes in
global protein structure of apo and holo L-FABP while more apparent differences were observed within the internal binding
pocket, revealing reduced area and structural integrity. New solvent accessible portals on the periphery of the protein were
observed following 4-HNE modification in both the apo and holo state, suggesting an adaptive response to carbonylation.
The results from this study detail the dynamic process associated with L-FABP modification by 4-HNE and provide insight as
to how alterations in structural integrity and ligand binding may a contributing factor in the pathogenesis of ALD.
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Introduction
Chronic ethanol consumption is a prominent cause of liver
disease and is responsible for significant morbidity and mortality
throughout the Western world [1,2,3]. The pathogenesis of
alcoholic liver disease (ALD) is progressive, complex, and highly
variable resulting in a range of histologic abnormalities including
steatosis and steatohepatitis. Disease progression is largely
regarded to be a result of the oxidative metabolism of ethanol
leading to an imbalance between pro-oxidant and antioxidant
mechanisms [4,5]. Previous reports have indicated initiation of
cellular dysfunction from increased reactive oxygen species (ROS)
by modifying and inactivating proteins, lipids and membranes,
and DNA [6]. The generation of ROS has also been shown to
result in the initiation of lipid peroxidation (LPO), whereby
reactive aldehydes are generated from the oxidation of polyun-
saturated fatty acids. Among the numerous aldehydes generated
from LPO is the a,b-unsaturated aldehyde, 4-hydroxy-2-nonenal
(4-HNE). This biogenic aldehyde is present under basal conditions
and can adduct nucleophilic protein side-chains, namely Cys ..
His . Lys residues through either Michael addition (MA) or Schiff
base (SB) reactions [6,7,8]. It has been estimated that up to 95% of
4-HNE MAs are stabilized in the form of cyclic hemi-acetals (HA)
[9,10,11]. The half-life of 4-HNE has been reported to be ,2
minutes; demonstrating that it can migrate from the site of origin
to other intracellular sites [7]. High levels of 4-HNE protein
adducts have been found in the livers of patients with hemochro-
matosis, Wilson’s disease, primary biliary cirrhosis, advanced
stages of ALD and in the serum of type 2 diabetes patients [12,13].
Given its high reactivity and ability to covalently modify proteins,
it is important to understand the consequence of protein adduction
by 4-HNE and how these reactions may contribute to the
pathogenesis and/or progression of numerous human disease
states.
Liver fatty acid-binding protein (L-FABP) coordinates lipid
responses in the cell by facilitating the cytosolic transport of fatty
acids (FA) to various compartments, including lipid droplets, the
endoplasmic reticulum, mitochondrion, peroxisomes, and the
nucleus [14]. L-FABP is comprised of ten antiparallel b-sheets
(bA- bJ) encapsulating a solvent-accessible ligand-binding pocket,
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ecapped by an N-terminal helix-turn-helix motif (aI-aII) [15]. It is a
unique member of the intracellular lipid-binding protein family in
that it can stoichiometrically bind two hydrophobic ligands, with
the highest affinity for long chain fatty acids (LCFA) [15,16,17].
These C12-C20 LCFA ligands are the substrates that perpetuate
the cycling of lipid peroxidation. The localization and function of
L-FABP directly places it within the microenvironment containing
reactive aldehydes; therefore, susceptibility to adduction by
reactive aldehydes remains high. Due to its high abundance in
the cell, accounting for up to 5% of total cytosolic protein in
hepatocytes, L-FABP is proposed to play an important role in
hepatic lipid homeostasis. Alterations in protein stability and
activity from aldehyde adduction may contribute to the changes in
lipid metabolism that are observed in disorders associated with
hepatic lipid accumulation such as ALD.
The expression of L-FABP is highly affected following ethanol
consumption, as demonstrated by an approximate 30% decrease
in rats [18]. This report also revealed immunopositive staining for
hepatic 4-HNE adducted L-FABP. The mechanisms for the
observed decrease in protein expression remain unknown;
however, it is possible that 4-HNE adduction results in a
destabilization of L-FABP, targeting the protein for degradation.
In the present study, we report a significant decrease in L-FABP
protein and FABP1 mRNA, as well as an increase in ubiquitin-
tated L-FABP following ethanol consumption in mice. We have
identified sites of 4-HNE adduction on both apo (unbound) and
holo (lipid-bound) L-FABP and have investigated the consequenc-
es of this modification on protein function, stability, and structure.
The impact of 4-HNE modification resulted in diminished ligand
binding, altered protein stability, and dramatic changes around
the ligand accessible portals of the protein. Data are also provided
demonstrating a significant impact of 4-HNE adduction on L-
FABP structural and functional dynamics that may be contributing
factors for altered lipid homeostasis in ALD.
Materials and Methods
Reagents
Unless otherwise specified, all reagents were purchased from
Sigma Aldrich (St. Louis, MO).
Ethanol Feeding Model
All protocols were approved by the Institutional Animal Care
and Use Committee (IACUC) at the University of Colorado
Anschutz Medical Campus. Male C57Bl/6J mice were fed a
modified Lieber-DeCarli Diet (BioServ, Frenchtown, NJ) consist-
ing of 45% fat-derived calories and 15% protein-derived calories
with the remaining caloric content derived from either ethanol or
maltose-dextrin. Mice were fed for a period of 6 weeks according
to previous laboratory studies [19,20]. At termination, the liver
was harvested for whole tissue and histological evaluation as
previously described [20,21]. Subcellular fractions were isolated
from whole liver tissue using sucrose gradient centrifugation [22].
2-Dimensional Gel Electrophoresis
Enriched cytosolic fractions were assessed utilizing 2D separa-
tion techniques as previously described [21,23]. Briefly, 250 mgo f
cytosolic protein was separated utilizing 11 cm IPG strips with a
pH gradient of 3–10 in a Protean IEF cell (Biorad Lifesciences,
Hercules, CA). Separation in the second dimension was performed
utilizing 11 cm 8–16% SDS-PAGE gradient gels (Biorad Life-
sciences). Protein gels were either stained with Imperial protein
stain (Thermofisher, Rockford, IL) or transferred to Polyvinylidene
fluoride (PVDF) and blocked with 5% non-fat dry milk (NFDM)
(w/v) in tris-buffered saline with 0.2% tween-20 for 30 min at RT.
The membranes were probed using a custom primary antibody
directed against 4-HNE modified proteins (Bethyl Laboratories,
Montgomery, TX) or L-FABP (Abcam, Cambridge, MA) utilizing
standard Western blotting techniques. Membranes were devel-
oped with enhanced chemiluminescence and scanned using a
STORM 860 Scanner (Molecular Dynamics, Sunnyvale, CA).
Developed Western blots were overlaid to stained protein gels and
immunopositive spots were carefully matched, excised and
digested with trypsin. Peptides were subsequently analyzed
utilizing an 1100 Series LC/MSD Trap (Agilent Technologies,
Santa Clara, CA). Protein identifications were made utilizing data
analysis software MASCOT, with protein identifications above 54
being significant hits.
Co-immunoprecipitation of Ubiquitinated L-FABP
200 ug of whole cell homogenates from both control and
ethanol mice (n=6/group) were incubated with 5 ug of mouse
monoclonal ubiquitin antibody (Abcam, cat# ab411) for 2 hours
at 4uC on a rotator to allow ubiquitin protein to bind to antibody.
100 ul of a 50% Protein G slurry (prepared and stored in 0.02%
sodium azide and PBS, pH 7.4) was added to the reaction and
incubated at 4uC rotating overnight. Samples were washed 565
minutes in PBST (PBS +2% Tween20) and denatured in SDS-
PAGE loading buffer at 95uC for 5 minutes. Immunoprecipitated
protein was separated via SDS-PAGE and transferred to PVDF,
and immunoblotted for L-FABP (Abcam, cat # 7847). Density of
ubiquitinated bands were normalized to levels of L-FABP/b-Actin
determined by immunoblotting.
RT-PCR Analysis of FABP1
Total RNA was isolated from 20 ug of frozen tissue from
control and ethanol-fed mice (n=3) using RNeasy Mini Kits
(Qiagen,Valencia, CA). 1 ug of RNA was reverse-transcribed to
cDNA at 42uC for 60 minutes using AMV reverse-transcriptase
(New England Biolabs, Ipswich, MA) with oligo(dT) Primers
(Invitrogen, Carlsbad, CA). cDNA was amplified using GoTaq
qPCR Master Mix (Promega, Madison, WI) and gene specific
primers for FABP1 (F: 59-GCA GAG CCA GGA GAA CTT TG-
39;R :5 9-GGG TCC ATA GGT GAT GGT GAG-39 [24] and
G3PDH (F: 59-GGT GTG AAC GGA TTT GGC CGT ATT-39;
R: 59-TGG AAG AGT GGG AGT TGC TGT TGA-39 [25]
(IDT, Coralville, IA).
Cloning, Expression and Purification of L-FABP
The L-FABP (FABP1) gene from mus musculus was TOPO cloned
into pET 100 vector (Invitrogen) from the pCMV-SPORT6 vector
containing clone #4159971 (Open Biosystems, Huntsville, AL).
All constructs were verified by sequence at the University of
Colorado Cancer Center, and transformed into BL21 (DE3)
Escherichia coli. Cultures were grown overnight with ampicillin
selection, and used to propagate a larger 1 L culture until OD600
reached 0.6–0.8. Cultures were then induced with 1 mM IPTG
for 4 hours, sedimented via centrifugation at 6,0006g, flash frozen
and stored at 280uC until purification. The bacterial pellet was
lysed in 50 mM tricine (pH 8.0), 500 mM NaCl, 1 mM b-
mercaptoethanol (BME), 1 mM EDTA, protease inhibitor cocktail
and lysozyme and sonicated using a Branson Digital Sonifier
(Danbury, CT). Following centrifugation, the supernatant con-
taining recombinant L-FABP (rL-FABP) was purified initially
using ammonium sulfate precipitation up to 65% saturation,
dialyzed overnight with three subsequent buffer changes of
50 mM Tricine (pH 8.0), and concentrated using an amicon
ultrafiltration stirred cell (Millipore, Billerica, MA). The protein
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Healthcare, Piscataway, NJ) with anion exchange chromatography
(HiPrep QX L 16/10). Purity of fractions were analyzed via SDS-
PAGE and Coomassie Blue staining and the final rL-FABP prep
was determined to be .95% purity. rL-FABP was delipidated
using established protocols [26,27]. The purified, delipidated rL-
FABP was stored in 1 mg/ml aliquots containing 10% sucrose at
280uC until required. For the holo (lipid-bound) isoform of rL-
FABP, protein was incubated with 1 mM linoleic acid (LA) (from a
10 mM stock solubilized in 100% ethanol) for 1 hour at 25uC
rotating end-over-end say followed by dialysis in tricine buffer
(pH 8.0) overnight at 4uC. Bound lipid was verified using an
established fluorescence assay [28,29].
Modification of rL-FABP with 4-HNE
rL-FABP was incubated with increasing molar ratios of 4-HNE
(0.5X, 1X, 5X, and 10X [5.85 mM, 11.7 mM, 58.52 mM, and
117.03 mM]) for 1 hour at 25uC in PBS (pH 7.4). Following
modification, samples were then reduced with 10 mM NaBH4 for
30 minutes at 25uC to trap transient adducts. Aldehyde-modified
rL-FABP protein samples were separated on a polyacrylamide gel
via standard SDS-PAGE procedures and stained with Coomassie
Blue.
Mass Spectrometry Analysis of rL-FABP
5 mg of 4-HNE treated r-LFABP (reduced and non-reduced)
was separated via SDS-PAGE and stained with Coomassie blue.
Bands were then excised, digested with sequencing-grade trypsin
(Promega, Madison, WI), purified using C-18 ziptips (Millipore)
and then spotted 1:1 with a-cyano-4-hydroxycinnamic acid matrix
onto an Opti-TOF 96-well insert (Applied Biosystems, Carlsbad,
California) for analysis. Peptides were analyzed on an ABI 4800
Plus Matrix-assisted laser desorption ionization time-of-flight
(MALDI-TOF/TOF) mass spectrometer using Reflector acquisi-
tion mode, potential 4-HNE adducts were then identified using
Mascot (v 2.1.04, www.matrixcience.com). Collision-induced
dissociation fragmentation was then utilized to acquire b/y ion
fragmentation spectra for adducted peptides, which were aligned
with predicted ion fragmentation pattern using ProteinProspector
v 5.4 (http://prospector.ucsf.edu, USCF Mass Spectrometry
Facility).
rL-FABP Binding and Displacement Using 1-
Anilinonaphthalene-8-Sulfonic Acid (ANS)
Steady-state fluorescence spectra were measured using a
HORIBA JOBIN YVON FluoroMax-3 Fluorometer (Edison, NJ
USA). The binding of ANS to rL-FABP was monitored following
excitation at 370 nm and emission at 475 nm, with slits set at 2
and 4 nm, respectively. Measurements were taken at ambient
temperature in a 0.7 mL fluorescence cuvette (Starna Cells,
Atascadero, CA). Equilibrium binding studies were conducted
with saturating concentrations of ANS according to previous
studies [29,30] with slight modifications. Briefly, ANS (0–45 mM)
was titrated into 1 mM rL-FABP in 50 mM tricine buffer (pH 8.0),
mixed for 30 seconds, and emission spectra were recorded. rL-
FABP was either treated with 4-HNE (0.1X [5.93 mM], 1X
[53.93 mM], or 5X [245.09 mM]) or the arginine blocker
phenylglyoxal (PG) (10 mM) [31], or a combination of the two
(PG +5X). Following treatments, protein was dialyzed overnight in
tricine buffer, pH 8.0. Preparation of ANS was conducted
according to Denicola et al. [29], where it was solubilized in
absolute ethanol and quantified at Abs372 with an extinction
coefficient of 8,000 cm
21?M
21 prior to use.
Lipid displacement assays were adapted from previous publica-
tions [28,30]. Briefly, lipids were used to displace ANS bound to
rL-FABP to assess how 4-HNE modification affects affinity
towards more biologic ligands. Lipid stocks were diluted in
absolute ethanol (10 mM, 5 mM, 1 mM, 0.1 mM) and prepared
in a nitrogen gas chamber. Using conditions similar to ANS
binding, increasing concentrations of FAs [stearate (SA), oleate
(OA), and LA] were titrated into a pre-equilibrated solution
containing 45 mM ANS, 1 mM r-LFABP, and 50 mM tricine
(pH 8.0). The sample was mixed for an additional 30 seconds and
the excitation and emission of ANS was measured as mentioned,
where the loss of fluorescence indicates affinity towards the lipid.
Thermal Denaturation of rL-FABP
The stability of rL-FABP was assessed using UV-monitored
heating experiments. Native (apo and holo) and 4-HNE modified
(apo and holo) rL-FABP (0.8 mg/ml) was thermally denatured in
50 mM tricine buffer (pH 8.0) at 40–95uC over 1.5 hours in a
0.7 mL quartz cell (Starna Cells). Absorbance of rL-FABP was
monitored at 260–360 nm using a Chirascan Plus Spectrometer
(Applied Photophysics, Leatherhead, Surrey, UK) once per
minute. Temperature was continuously ramped 1uC/min. Light
scattering was recorded continuously at 360 nm to monitor
protein aggregation [32]. Temperature of aggregation (Tm) was
determined using Global Analysis T-Ramp software provided by
Applied Photophysics (Pro-Data Global3 v1.1.0) following baseline
correction.
Molecular Modeling
All simulations were performed using Discovery Studio software
(v3; Accelrys Inc., San Diego, CA). The crystallographic
coordinates of the 2.3A ˚ rat FABP1 crystal structure (PDB:
3GLS) [33] were obtained from the RCSB Protein Data Bank
(http://wwww.rcsb.org) and used to generate a homology model
of the mouse FABP1 crystal (PDB 1LFO, 98% sequence identity)
[33]. The sequences of the proteins were aligned and five
homology models were created and structural evaluation was
performed on the basis of discrete optimized protein energy score
[34]. The most energy favored intermediate was retained and the
residues were corrected for physiological pH. The homology
model was refined using CHARMm and subjected energy
minimization (steepest descent, 100 iterations; conjugate gradient,
1000 iterations) to a convergence of 0.001 kcal/mol using the
Generalized Born implicit solvent model. The minimization of the
native apo L-FABP resulted in an overall potential energy of
3993.5 kcal/mol. Michael adducts of 4-HNE were built onto the
Cys69 and Lys57 residues and the model was subject to a further
round of minimization. LA was docked into the binding pocket of
the unadducted FABP1 homology model using the flexible
docking protocol [35],and the Generalized Born method was
used to calculate binding energies (DGbind) [36], with a non-
bonded cut-off radius of 12A ˚. The LA molecules adopted similar
conformations as OA, which has been previously co-crystalized
with rat L-FABP [33]. The DGbind for LA at the base of the
FABP1 binding pocket was 235.6 kcal/mol and 235.7 kcal/mol
at the entrance of the binding pocket. The total potential energy
post-minimization of native holo L-FABP was 7983.2 kcal/mol.
Michael addition and Schiff base 4-HNE adducts were then built
onto Cys69, His43, Lys31, Lys57, Lys6 and Lys46 residues and the
complex was subjected to energy minimization. Cyclic HA 4-HNE
adducts were also built in place of the MA adducts on apo and
holo L-FABP and subjected to energy minimization.
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Statistical analysis and generation of graphs was performed
using GraphPad Prism (v 4.02; GraphPad Software, San Diego,
CA) and SigmaPlot (v10.0; Systat Software, San Jose, CA).
Statistical differences between control and treated samples were
assessed using a paired Student’s t test or a one-way ANOVA with
Tukey’s post-test. Differences were considered significant if
p,0.05. Nonlinear regression (curve fit) analysis was performed
using a two-site binding hyperbola (eq 1), where DF is the
enhancement in fluorescence intensity upon the binding of ANS to
L-FABP to a point of saturation (Bmax).
DF~Bmax1|
ANS ½ 
Kd1z ANS ½ 
zBmax2|
ANS ½ 
Kd2z ANS ½ 
ð1Þ
For the displacement assays, one-site inhibition analysis of the
data was utilized based on the fit of the data (instead of a two-site
inhibition analysis) (eq2). Fluorescence counts that are inhibitable
are denoted as bi, and residual counts are br. The concentration of
OA, SA or LA is denoted as [FA]. The Hill constant, g, indicates
the cooperativity between the binding sites, where if g .1 the sites
are positively cooperative, g ,1 the site are negatively cooper-
ative, and if g = 1 the sites are non-cooperative.
DF~
bi
1z FA
kd
   g
"#
zbr ð2Þ
Results
Hepatic L-FABP is a Target for Modification by 4-HNE in
Ethanol-fed Mice
LPO is a known consequence to sustained ethanol consumption,
and identifying protein targets for modification by reactive
aldehydes may further elucidate mechanistic information for the
progression of specific diseases. Mice fed an ethanol-containing
diet for 6 weeks has been shown to result in significant hepatic
alterations consistent with early liver injury, including increased
plasma ALT activity, increased liver triglyceride accumulation,
and hepatomegaly [19,20]. As shown in Figure 1A, the 2D gel
immunostained for 4-HNE protein adducts of the ethanol-fed
mice displayed a marked increase in 4-HNE-modified proteins.
We have identified 48 unique proteins from 39 4-HNE
immunopositive spots from hepatic cytoplasmic fractions of mice
fed chronically with ethanol for 6 weeks. Of the 39 spots, 34
received significant protein identifications (Table S1). Interesting-
ly, 4-HNE immunopositive spots are present in the control gels,
but to a lesser degree as compared with the ethanol group. The
presence of 4-HNE in the control is expected as submicromolar to
micromolar concentrations of 4-HNE have been shown to induce
homeostatic, cell-specific effects such as stimulation of proliferation
and regulating signaling pathways [37]. Of the proteins identified,
our focus remained on L-FABP due to its pivotal role in hepatic
FA uptake and trafficking. Following tryptic digest, 4 peptides of
L-FABP were identified from the 2D gels, with 34% sequence
coverage and a significant MASCOT score of 303. To verify spot
identification, paired gels were probed with an antibody directed
against L-FABP. Compared with the control gel, the ethanol-fed
sample showed a reduction in the total expression of L-FABP;
correlating with previous data observed in rats [18]. In Figure 1B,
we confirm the ,80% reduction in L-FABP by 1D Western Blot
analysis in whole cell lysates of control and ethanol-fed mice
(P,0.001, n=6). In Figure 1B and 1C the stability of L-FABP was
assessed in vivo. Co-immunoprecipitation of ubiquitinated L-FABP
revealed a significant increase in poly-ubiquitinated L-FABP in
response to ethanol treatment when normalized to the total L-
FABP protein pool (P,0.001, n=6). Figure 1D shows RT-PCR of
FABP1 mRNA, which revealed a 1.6 fold decrease in message
following ethanol treatment. Relative expression of FABP1 in
control (1.0060.084) and ethanol (0.61760.069) livers (P,0.05,
n=3).
Identification of 4-HNE Adducts on Both Apo and Holo
rL-FABP
L-FABP exhibits a high affinity for a vast range of hydrophobic
ligands, including LCFA [38]. Structurally, L-FABP changes
conformation depending on the apo or holo state [39]; it was
therefore hypothesized that 4-HNE adduction would differ based
on the binding state of the protein. Based on the complications of
identifying in vivo modifications, adduction of rL-FABP by 4-HNE
was performed in vitro to identify specific sites of modification in
apo and linoleate-bound protein. As demonstrated in Table 1,
MALDI-TOF/TOF analysis of digested rL-FABP revealed two
MA 4-HNE adducts on apo rL-FABP, at Lys57 and Cys69 with
sequence coverage of 89% and 87%, respectfully. The holo form
revealed six total adducts with 90% sequence coverage. These
were identified at Lys31, His43, Lys57 and Cys69 MA and Lys6
and Lys46 SB adducts. Figure 2A and 2B display the MS/MS
spectrum of parent ions containing Cys69 of apo rL-FABP and
Lys46 of holo rL-FABP, where relative y and b ions confirm all 4-
HNE adducts on rL-FABP. The remaining MS/MS spectra of the
4-HNE adducted peptides also confirmed modifications on Lys57,
His43, Lys6, and Lys31 of rL-FABP (Figures S1 and S2).
4-HNE Adduction Alters the Capacity and Affinity for ANS
To further assess the functional effects of 4-HNE adduction on
L-FABP, a well-established binding assay utilizing ANS was
performed. As shown in Figure 3, a significant, concentration-
dependent reduction in the capacity and affinity for ANS was
observed following adduction with pathologically relevant con-
centrations of 4-HNE. Table 2 contains the regression analysis
comparing the native and 4-HNE adducted rL-FABP. The
dissociation constants in the primary binding site show increased
affinity for ANS at lower concentrations of 4-HNE (0.1X,
kd1=0.13260.074 mM and 1X, 0.13560.074 mM compared to
native (0X, 0.34760.153 mM ) but relatively minor changes at the
highest concentration assessed (5X, kd1=0.39560.101 mM ). The
Figure 1. L-FABP was identified as a 4-HNE modified protein in cytosolic fractions of mice chronically treated with ethanol utilizing
2D SDS-PAGE and LC-MS. (A) 48 proteins in 39 spots were identified from 2D gels by matching up immunoblots probed with an anti-4-HNE
antibody created in our lab. Immunoblots from both control and ethanol-fed mice reveal an increase in the total pool of 4-HNE modified proteins. A
second set of gels were probed for L-FABP, while a third set was stained with imperial and used for protein excision, tryptic digest, and LC-MS
identification. (B) In vivo stability of L-FABP was assessed via measurement of ubiquitin-tagged protein by co-immunoprecipitation with ubiquitin
antibody. (C) Relative quantification of poly-ubiquitinated L-FABP was normalized to total L-FABP in the liver (P,0.001, n=6). (D) FABP1 mRNA was
measured by qPCR (P,0.05, n=3).
doi:10.1371/journal.pone.0038459.g001
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decrease in the affinity for ANS following 4-HNE modification at
the highest 4-HNE treatment (0x, kd2=6.1761.44 mM compared
to 5X, kd2=34.20613.85 mM). The Bmax1 values of 4-HNE
modified rL-FABP compared to the native protein demonstrate
reduced capacity in the primary site following 4-HNE modifica-
tion in a concentration dependent manner. The Bmax1 is reduced
the most by PG (83, 200623,200 AFU) compared to native
(540,2006142,500 AFU), consistent to previously published
reports [31]. We also observed that Bmax2 values remain relatively
unchanged following 4-HNE adduction.
Figure 2. 4-HNE adducts were identified on apo and holo rL-FABP via MALDI-TOF/TOF Mass Spectrometery. Following incubation with
reactive aldehyde, rL-FABP was found to be modified in both the apo and holo form. MS/MS spectra from 4-HNE treated apo rL-FABP revealed the
presence of two protein adducts, at residues Lys57 and Cys69. The same experiments were conducted with holo rL-FABP and revealed an additional
four 4-HNE adducts on Lys31, Lys46, Lys6, and His 43. Identified b/y ions are labeled within the spectrum and shown along the peptide backbone
above the spectrum. The parent ion of the MS/MS fragment is shown as an inset in the upper right corner of the spectrum.
doi:10.1371/journal.pone.0038459.g002
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The effects of 4-HNE modification on the affinity and capacity
of L-FABP towards natural ligands, including FA, were analyzed
using a well-documented ANS displacement assay. As demon-
strated in Figure 4 and Table 3, 4-HNE reduces the maximal
binding to the FA tested by 41% for SA, 32.7% for OA, and 49%
for LA, respectively. The inhibition constants of adducted rL-
FABP increased from the native protein for SA and LA, but
decreased for OA. These data indicate that 4-HNE modification
may affect the specificity towards ligands despite showing a
decrease in the overall capacity of the system. The Hill constants
indicate positive cooperativity for WT and 4-HNE adducted rL-
Table 1. rL-FABP peptides identified with 4-HNE Michael addition and Schiff bases adducts.
Residues Mass Miss Sequence Peptide Type
Mass
Shift Molar Excess 4-HNE
4-HNE
[mM]
Apo rL-FABP 61–78 2215.98 0 NEFTLGEECELETMTGEK Cys69 MA 156 10X* 117.03
61–78 2231.98 0 NEFTLGEECELETM(ox)TGEK Cys69 MA 156 10X* 117.03
Holo rL-FABP 61–78 2231.94 0 NEFTLGEECELETM(ox)TGEK Cys69 MA 156 10X* 117.03
Apo rL-FABP
Reduced
50–60 1404.87 1 LTITYGPKVVR Lys57 MA 158 0.5X*, 1X*, 5X*, 10X* 5.85, 11.7,
58.52,
117.03
Holo rL-FABP
Reduced
61–78 2233.98 0 NEFTLGEECELETM(ox)TGEK Cys69 MA 156 1X*, 5X*, 10X* 11.7,
58.52,
117.03
50–60 1404.87 1 LTITYGPKVVR Lys57 MA 158 10X* 117.03
37–46 1212.65 0 GVSEIVHEGK His43 MA 158 0.5X, 1X*, 5X*, 10X* 5.85, 11.7,
58.52,
117.03
21–33 1539.89 1 AIGLPEDLIQKGK Lys31 MA 158 5X*, 10X* 58.52,
117.03
19-Jan 2609.17 1 M(ox)NFSGKYLQSQENFEPFMK Lys6 SB 140 10X* 117.03
19-Jan 2625.16 1 M(ox)NFSGKYLQSQENFEPFM(ox)K Lys6 SB 140 1X, 5X, 10X* 11.7,
58.52,
117.03
50–60 1386.85 1 LTITYGPKVVR Lys57 SB 140 5X, 10X* 58.52,
117.03
48–60 1628.03 2 IKLTITYGPKVVR Lys57 SB 140 5X, 10X* 58.52,
117.03
37–47 1322.75 1 GVSEIVHEGKK Lys46 SB 140 5X, 10X* 58.52,
117.03
*indicates conformation of protein adduct by MS/MS.
Type of adduct refers to either (1) MA = Michael addition or (2) SB = Schiff base.
Modifications were identified on Cys69 of both apo and holo rLFABP. Following reductive stabilization with sodium borohydride in both apo and holo rL-FABP, transient
adducts were identified at His43, Lys6, Lys31, Lys57, and Lys46.
doi:10.1371/journal.pone.0038459.t001
Figure 3. The binding profile of apo rL-FABP is adversely affected following 4-HNE adduction. Utilizing the fluorescent probe, ANS,
equilibrium binding studies of native and 4-HNE modified r-LFABP revealed alterations in both affinity for ANS and maximal binding capacity for
ligands when the protein is modified. PG, an arginine blocker, is used as a control for 50% of maximal binding. Blue - 0X 4-HNE; green-0.1X 4-HNE
(5.93 mM); yellow-1X 4-HNE (53.95 mM); orange-5X 4-HNE (245.09 mM); red-PG (10 mM); purple-5X 4-HNE + PG.
doi:10.1371/journal.pone.0038459.g003
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displaced with OA.
Stability Profiles of Native and 4-HNE Adducted L-FABP
Differ in the Apo and Holo States
Consequences of 4-HNE modification commonly include
protein inactivation and destabilization [40]. To further examine
the effects of aldehyde adduction and destabilization of L-FABP, a
thermal denaturation assay was employed. Figure 5A shows that
apo rL-FABP (Tm=71.8260.09uC) is sensitive to degradation
following 4-HNE modification in a concentration dependent
manner (0.1X, Tm=70.0960.004uC; 1X, Tm=68.5660.05uC;
5X, Tm=66.3860.15uC; p,0.01). Contrary to apo rL-FABP,
Figure 5B demonstrates that the thermal stability of holo rL-FABP
(Tm=86.0960.57uC) is only moderately affected following 4-
HNE adduction (0.1X, Tm=83.8460.39uC; 1X,
Tm=84.8960.48uC; 5X, Tm=83.69860.53uC). Apo and holo
stability may also be related by comparing the slope of the thermal
melts, with the apo being far steeper than the holo indicating a
faster transition between the folded and unfolded state. Consistent
with previous reports, it is evident that lipid binding by FABP
results in a significantly more stable product [41]. The Tm from
the holo rL-FABP remains semi-quantitative as maximal temper-
ature (98uC) does not result in a fully aggregated state. These data
suggest that 4-HNE adduction only minimally affects holo rL-
FABP protein stability.
Molecular Modeling Reveals Slight Structural Changes
Following 4-HNE Adduction
We have identified peripheral 4-HNE adducts on both the apo
and holo rL-FABP utilizing MALDI-TOF/TOF studies. The
structural consequence of these modifications was further inves-
tigated in the present study utilizing in silico simulations. Figure 6
demonstrates that the minimizations of these models resulted in
minor structural differences between native, 4-HNE adducted,
and the cyclized 4-HNE HA L-FABP in apo and holo states,
respectively. Table 4 reveals the degree of structural shift between
the alpha carbons (Ca) of portal 1 (Lys28, Lys31, Pro56), portal 2
(Ile22, Glu77, Lys96), and portal 3 (Ile48, Asp88, Gly105) in the 4-
HNE adducted structures and the native protein. These indicate
subtle structural changes occurring throughout the entire protein
as a consequence of peripheral 4-HNE adduction, with the
greatest shifts being under 3 A ˚.
Utilizing PROPKA (http://propka.ki.ku.dk/), the predicted
pKa and solvent accessibility of the six 4-HNE susceptible residues
were calculated in the native protein. Modified residues in apo and
holo-L-FABP are variable for all residue types, indicating that
there is a range of ‘‘optimal’’ factors for 4-HNE to react with
protein side-chains. More specifically, it appears the nucleophilic
softness and chemical potential are more important factors than
pH to regulate the nucleophilicity of an amino acid [42]. In the
apo state, Lys57 and Cys69 are 21% and 11% buried from the
solvent, with a pKa value of 10.22 and 10.07, respectively. In the
holo state, Cys69 and His43 are both 37% buried with a pKa of
9.57 and 5.23. Lys6, Lys 31, Lys46, and Lys57 in the holo state are
more solvent accessible (4%, 0%, 0% and 28% buried) with
similar pka values (10.97, 12.33, 10.49 and 9.61). The ‘‘percent
buried’’ factor of the residue reveals that solvent accessibility
remains highly important for 4-HNE adduction to occur i.e. the
most buried residues are Cys69 and His43 on holo L-FABP at
37% each.
To further examine the effects of peripheral 4-HNE adduction,
Figure 7 shows the lipophilic surface maps that were applied to
visualize ligand portals and the internal binding cavity of native
and 4-HNE adducted L-FABP. Figure 7A shows that in the apo
state, a well-defined ligand entrance site at portal 1 and interior
binding cavity exist throughout the b-barrel with an internal
binding area of 1,116.38 A ˚ 3. Figures 7C and E reveal that upon 4-
HNE adduction, the binding pocket exhibits diminished solvent
accessibility at portal 1 and reduced areas of 634.125 A ˚ 3 and
597.125 A ˚ 3, respectively. In the holo state, more dramatic effects
of aldehyde adduction are evident, where the binding pocket loses
almost all structural integrity. Native holo L-FABP retains an
internal binding area of 705 A ˚ 3 in the presence of two LA ligands
as shown by Figure 7B; Figure 7D and F reveal that the 4-HNE
modified L-FABP possess areas of 143.375 A ˚ 3 and 404 A ˚ 3 with
reduced ligand access at portal 1 compared to native holo L-
FABP.
Interestingly, when adducted in the ‘‘open chain’’ form, a new
solvent accessible portal (P4, red asterisk) appears below portal 2,
between the bG-bH strand interface of apo L-FABP in Figure 8C.
In the holo state, an alternative solvent accessible portal was
observed at a different position on the protein. When adducted, a
new portal also appears below portal 1 between bD-bE as shown
in Figure 8D and F (P5, red asterisk). Reference residues around
the binding portals were examined at the a carbons to detect
changes in the spacial orientation following 4-HNE adduction.
These amino acid maps show minimal changes in the 3-
dimensional maps surrounding portals 1 and 2 (Figure S3).
Therefore, we can attribute these changes in portal solvent
accessibility to the changes in the amino acid side chains in the
presence of 4-HNE adducts.
Discussion
Electrophilic products of LPO are reactive molecules that can
interact with lipids, proteins and DNA [6]. 4-HNE remains one of
the most widely studied aldehydic products of LPO, due to its high
prevalence among protein carbonyls and its detection in tissues of
patients and animal models of diabetes, cardiovascular disease,
chronic obstructive pulmonary disease, nonalcoholic fatty liver
Table 2. Equilibrium binding data utilizing the fluorescent probe ANS.
L-FABP PG 0.1X 1X 5X 5X+PG
Bmax1 (AFU) 540,2006142,500 83,200623,200 175,500636,800 123,000628,900 238,100621,700 168,200622,900
Kd1 (mM) 0.34760.153 0.16560.111 0.13260.074 0.13560.074 0.39560.101 0.32660.127
Bmax2 (AFU) 500,5006116,800 446,400617,500 903, 400628,300 548,900623,700 537,400681,900 512,200664,500
Kd2 (mM) 6.1761.44 7.1860.121 7.4061.07 4.9960.71 34.20613.85 27.89610.71
Values presented are mean 6 SEM of two independent experiments consisting of at least 3 replicates. AFU denotes arbitrary fluorescent units.
doi:10.1371/journal.pone.0038459.t002
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adduction by reactive aldehydes affects proteins in the cell may aid
in elucidating the pathogenesis of a multitude of disease states. The
consequences of protein adduction have been reported to affect
protein activity, stability and conformation [21,46,47,48,49,50].
Currently, protein carbonylation is used as a biomarker for
oxidative damage in humans [51,52]. Therefore, identifying
protein targets susceptible to 4-HNE modification in vivo may
provide mechanistic insight into disease progression. Utilizing
proteomics-based approaches, we have begun to identify these
proteins following ethanol exposure in mice [19,20,21,53,54].
Based on previous reports from our laboratory, we have
hypothesized that because of its role in in lipid uptake and
trafficking, 4-HNE-modified L-FABP may be a contributing factor
to the observed accumulation of lipid within hepatocytes in early
stages of ALD. This highly expressed protein is severely decreased
at the protein level following sustained ethanol consumption and
was found through proteomic screens to be immunopositive for 4-
HNE [18]. Evidence shows detrimental effects of ethanol
consumption on metabolic pathways and 4-HNE adduction of
L-FABP may provide a potential mechanism for the observed
alterations in hepatic lipid homeostasis [24,55]. Consistent with
previous finding in rats [18], a mouse model of ethanol feeding
identified L-FABP as 4-HNE immunopositive, and was associated
with a decrease in the FABP1 mRNA and total L-FABP protein
pool following ethanol exposure. Other reports have agreed with
our results, indicating .50% decrease in the mRNA of FABP1
following a 4 week ‘‘ramped’’ ethanol feeding regimen [56].
However, an earlier publication stating that L-FABP contributes
to the increased hepatic cytosolic protein pool in rats following
chronic alcohol ingestion contradicts our findings [57]. The
interpretation of these data result from less direct measurements of
hepatic protein content utilizing gel filtration chromatography and
radial immunodiffusion techniques, and may explain the discrep-
ancies between our findings. Lu et al. have also reported that
ethanol feeding for 4 weeks in female SV/129 mice had no effect
on the levels of L-FABP [58]. It should be noted that this model
utilized female mice on a SV/129 background and our studies are
conducted on male mice on the C57/Bl6 background – which
may explain differences between studies.
Two other members of the lipid binding protein family, adipose
(A-FABP) and epithelial (E-FABP) isoforms, are known targets of
4-HNE modification [59,60]. 4-HNE modified A-FABP has been
identified from the adipose tissue of obese mice, and is
hypothesized to contribute to insulin resistance [60]. 4-HNE
modified E-FABP has also been identified in retinal homogenates
of rats and this lipid binding protein is proposed to function as an
antioxidant protein by scavenging lipoxidation end-products from
the cellular environment [59]. Sequence homologies of A-FABP
and E-FABP (,60%) link the cysteine adducts to be at similar
positions within the binding pocket (Cys120 and Cys117);
however, L-FABP does not contain this cysteine residue. Identified
adducts on L-FABP are prevalent along the periphery of the
protein: Cys69, His43 and Lys46 are located at the bottom of the
b-barrel near portal 3 at bE, bB and bC respectively; Lys31 and
Lys57 surround portal 1 at bD and aII; Lys6 is located on bAo f
the b-barrel further away from designated portals. Many of the
adducted amino acids identified in this study play important roles
as constituents of ligand accessible portals – indicating that even
steric hindrance of these portals by 4-HNE may explain the
reduced binding capacity and affinity for ligands. As previously
mentioned, L-FABP binds two FA, with the first ligand interacting
with residues on the interior of the binding pocket and the
carboxyl group of the second ligand interacting directly with Lys31
and Ser56 at the surface of portal 1 [39,61]. Lys31 and Lys57,
amongst other amino acids, constitute Portal 1 and are involved in
electrostatic interactions [15,33,62], further supporting the poten-
tial implications of 4-HNE adduction on these peripheral lysine
residues. Due to the nucleophillic nature of some of these targets, it
is highly possible that they may have absolutely no contributions to
Figure 4. Affinity and total binding capacity for fatty acids is
diminished following 4-HNE modification. The displacement of
ANS by natural ligands of L-FABP is shown in both native and 1X 4-HNE
(53.95 mM) treated rL-FABP. Displacement profiles of rL-FABP reveal loss
of both the affinity and the total capacity for SA (A), OA (B), and LA (C).
doi:10.1371/journal.pone.0038459.g004
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amino acid that is not near the established ligand portals. 4-HNE
reacts with the side chains of Cys .. His . Lys residues via MA
at C3 or SB reactions at C1. Both of these reactions with 4-HNE
were observed on multiple residues of rL-FABP when chemically
stabilized. Further analysis of the functional effects of 4-HNE
adducts on L-FABP revealed decreased binding, alterations in
protein stability, changes in the internal binding pocket and
solvent accessible portals. Collectively, these data present evidence
for the detrimental effects of 4-HNE modification on L-FABP in
vitro.
It is difficult to predict the physiological and/or pathological
relevance of transient-type lysine-4-HNE adducts in vivo. The
consequences of reversible modifications are unknown, but may
act in a protective manner by reducing irreversible oxidation and
modulating protein function [52]. Alternatively, transient 4-HNE
Table 3. Displacement of ANS by stearic, oleic, and linoleic fatty acids.
WT 1XHNE
FA bi (AFU) ki (mM) br (AFU) n bi (AFU) ki (mM) br (AFU) n
Stearic Acid 698,800619,400 1.1960.13 145,800614,400 2.7560.264 411,800636,800
# 4.4161.66 81,300630,500 2.7460.37
Oleic Acid 680,200626,500000 5.8861.45 171,600619,800 2.3160.29 457,600626,400
# 0.6960.097 63,500619,200 0.8160.0999
Linoleic Acid 888,000654 1.5660.29 164,800643,900 1.3860.26 449,500611,400
# 2.8060.30 96,30069,200 1.7660.14
# P,0.01
F=(b i/[1+([FA]/kd) ˆg]) + br, where bi denotes the counts inhibitable, ki the inhibition constant, br the counts residual, g the hill coefficient and AFU the arbitrary
fluorescent units. Values presented are mean 6 SEM of duplicate independent experiments comprised of 3 or more replicates. All concentrations FA are mM.
doi:10.1371/journal.pone.0038459.t003
Figure 5. Adduction affects protein stability only when in the apo form. Thermal denaturation of apo and holo native and 4-HNE treated
protein revealed differences in stability profiles. (A) The stability of apo rL-FABP decreases in a 4-HNE concentration dependent manner. (B) Holo rL-
FABP thermal stabillity is only moderately affected by 4-HNE adducts. Blue - 0X 4-HNE (0 mM); green - 0.1X 4-HNE (4.93 mM); yellow - 1X 4-HNE
(49.26 mM); orange - 5X 4-HNE (246.31 mM).
doi:10.1371/journal.pone.0038459.g005
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certain hydrophobic ligands and/or (2) potentially cross-links to
other hepatic proteins to regulate their stability/activity. A total of
six amino acids were identified as targets of 4-HNE adduction in
an in vitro-based system. Efforts to identify sites of adduction in vivo
were conducted using highly sensitive MS instrumentation coupled
with L-FABP enrichment strategies, yet were unsuccessful. The
techniques employed herein identified L-FABP as a target of 4-
HNE adduction; however, sensitivity and specificity may be rate-
limiting, further complicating identification of low-abundant in vivo
Figure 6. Molecular modeling simulations reveal minimal conformational changes in both apo and holo L-FABP as a result of
peripheral 4-HNE adducts. Native apo (A) and holo (B) L-FABP is shown as the grey ribbon structure, ‘‘open chain’’ 4-HNE adducts and HA 4-HNE
structures are shown as overlays over native protein, in blue (C and D) and purple (E and F), respectively. All structures are shown as a ‘‘front view’’
and 90u turned ‘‘side view’’. Reference residues surrounding the three ligand portals are shown in black of the apo native structure and have been
highlighted previously [62]. Root-mean-square deviation (RMSD) values were obtained comparing 4-HNE modified protein to the native. Residues
found to be modified with 4-HNE are labeled in red, and are referenced in all protein structures. Docked LA is colored according to the 4-HNE
adduction state: native = orange, 4-HNE = yellow, 4-HNE HA = green.
doi:10.1371/journal.pone.0038459.g006
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FABP in vivo analyses were much less compared to those of the in
vitro experiments (34% versus 90%, respectively) and may
contribute to the difficulty of identifying specific sites of adduction.
Due to limitations in enrichment strategies, it is difficult to
speculate on the percentage of adducted L-FABP found in the
livers of ethanol-fed mice. Recent findings suggest that highly
expressed proteins mask the detection of low-level aldehyde targets
[64,65].
Impacting hepatic uptake and trafficking of lipids through loss
of L-FABP protein/function has been demonstrated through the
use of L-FABP
2/2 models [66,67,68]. Knock-out mice exhibit
decreased FA binding capacity and altered distribution of lipids –
with 2–3 fold higher molar ratios of cholesterol/cholesterol ester,
cholesteryl ester/triglyceride, and cholesterol/phospholipid [67].
L-FABP deletion inhibits LCFA uptake, reduces LCFA intracel-
lular transport/diffusion and inhibits LCFA esterification and
oxidation [17]. In addition, L-FABP gene ablation reduces nuclear
distribution of LCFA and peroxisome proliferator-activated
receptor-a activity [69,70]. Capacity to regulate these processes
are clearly altered in early ethanol-induced liver injury, and loss of
function/translation of L-FABP may explain some of the hepatic
alterations in lipid homeostasis.
Equilibrium binding assays revealed changes in affinity and
capacity to bind in both sites in a concentration dependent
manner, but the effect was not completely inhibitory. When A-
FABP was modified with 500 mM 4-HNE a less dramatic effect
was observed, exhibiting a Kd of 23.20 mM when modified
compared to a Kd of 2.05 mM of the native protein [60]. It should
be noted that these concentrations of 4-HNE are above what are
thought to be involved in pathological disease states. Basal
concentrations of 4-HNE in many tissues and serum are predicted
to be below 0.1 mM and can range from 3.8 mM up to 100 mMi n
a stressed liver [6,71,72]. 4-HNE treatments in our studies were
maintained within physiological and pathological concentrations
of 4-HNE to retain relevance to disease pathogenesis. In the
present study, non-linear regression analysis showed that very low
concentrations of 4-HNE actually increased affinity toward ANS
in the primary binding site. These data suggest that lower
concentrations of 4-HNE may provoke a regulatory effect on L-
FABP ligand binding and mediate the specificity of ligands and
their respective destinations to various cellular compartments. It is
established that two factors confer selectivity towards ligands (1)
increased hydrophobicity of the ligand (2) and the electrostatic
interactions of the surface residues around portals [73,74]. In
addition to recognizing that steric hindrance around the portals
may be contributing to decreased binding ability, changes in the
electrostatic interactions of proximal residues (i.e. lysine residues)
due to 4-HNE adduction (similar to previously published reports
[75,76]) may contribute the alterations in ligand specificity that we
observe in our in vitro experiments. 4-HNE adduction also lowers
affinity for SA and LA, but increases affinity for OA. It was
observed with all FA displacement curves that the total capacity to
bind was severely diminished following 4-HNE adduction. The
results from these displacement assays provides further evidence
that these pathological concentrations of 4-HNE have the
potential to mediate ligand specificity within the cell.
It has been well documented that post-translational modifica-
tion of proteins, including 4-HNE adduction, affects conforma-
tional stability and function [11,18]. We have indirectly assessed
the stability of L-FABP in vivo by quantifying the amount of
ubiquitinated protein in response to the ethanol diet. The
ubiquitin system targets hydrophobic lysine residues exposed on
denatured protein, providing mechanistic insight to global protein
stability [77]. Ethanol increases the amount of poly-ubiquitinated
L-FABP, further supporting our in vitro denaturation studies in vivo.
The stability of rL-FABP following 4-HNE adduction is highly
regulated by the binding state of the protein. In the apo form, 4-
HNE adduction was detrimental to protein stability in a
concentration dependent manner; however, holo rL-FABP
adducted with 4-HNE revealed the aldehyde had modest effects
on global protein stability. Modification of E-FABP with 4-HNE
showed similar effects on protein stability, assessed via chemical
denaturation with guanidine hydrochloride in the apo state [59].
Binding of substrates and/or cofactors have been shown to
increase the thermostability of proteins, demonstrated with heat
shock protein 70 [78]. It is unknown whether 4-HNE modified L-
FABP in the holo state is a highly prevalent species and future
studies are in order to fully understand the altered stability and
these implications in vivo.
Changes in global L-FABP structure resulting from 4-HNE
modification were assessed in silico. Protein conformational shifts
can be attributed to several important physiological processes,
including (but not limited to) cofactor/substrate docking, solvent
pH, and post-translational modifications like 4-HNE adduction. 4-
HNE adducted apo and holo L-FABP minimized structures
revealed slight but minimal differences in global conformation
compared to the native protein, as shown by the RMSD values.
This was also demonstrated by modest changes in the difference in
distance of the alpha carbons of reference residues between native
and 4-HNE modified L-FABP. These homology models show
variations in the orientations of the bound LA in each binding site.
We also observed reductions in the internal binding pocket of both
apo and holo L-FABP following 4-HNE adduction. These reduced
Table 4. Distance of alpha carbons of critical reference residues surrounding the three ligand portals of L-FABP.
Ca Shift in Reference
Residues (A ˚) Portal 1 Portal 2 Portal 3
28 31 56 22 77 96 48 88 106
Apo L-
FABP
4-HNE Adduct 0.781 1.93 0.585 0.56 0.919 0.567 2.505 0.494 0.937
Hemiacetal 0.62 0.303 0.784 0.508 0.976 0.844 2.046 0.24 0.864
Holo L-
FABP
4-HNE Adduct 0.492 0.599 1.04 1.459 0.339 1.032 1.679 0.766 1.224
Hemiacetal 1.242 0.904 0.395 1.689 0.201 0.947 0.684 0.577 1.236
These alpha carbons (Ca) of portals 1 (Lys28, Lys31, Pro56), 2 (Ile22, Glu77, Lys96), and 3(Ile48, Asp88, Gly105) in the 4-HNE adducted structures were compared to those
of the native protein to identify structural shifts.
doi:10.1371/journal.pone.0038459.t004
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PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e38459areas may also confer selectivity for less bulky ligands (instead of
heme, bile salts, cholesterol, etc.) and favor smaller, more flexible
compounds. Considering this possibility, L-FABP may function
more like intestinal FABP (I-FABP). It has an internal binding
pocket approximately half that of L-FABP (234 A ˚ 3 versus 440 A ˚ 3)
and specifically binds LCFA at a 1:1 ratio, with lower affinities for
unsaturated FA [15,33].
Solvent mapping around the binding portals revealed substan-
tial changes in established portal accessibility and formation of
new solvent accessible portals throughout L-FABP structure,
regardless of binding state. These results indicate that the
functional dynamics that regulate L-FABP may be attributed to
the side-chains of a few peripheral amino acids surrounding the
binding portals. L-FABP may also be adapting to these modifi-
cations and still functioning to bind lipids, just at a reduced
capacity. It is unknown whether other post-translational modifi-
cations (PTM) exhibit similar effects on predicted ligand portals.
When Cys69 is glutathionylated, the binding profile is not altered;
but the modified species is more susceptible to proteolysis [79,80].
It has been reported that acetylation of surface lysine residues does
not change tertiary structure nor contribute to altered binding
properties [81,82]. This PTM, however, cannot be compared to 4-
HNE; there is a greater effect of steric hindrance from the longer
chain length of the aldehyde. In summary, this report has
demonstrated the dynamic processes involved with 4-HNE
adduction of L-FABP, providing new evidence for cellular
Figure 7. The structural integrity of the binding pocket is significantly affected following 4-HNE adduction. Lipophilic surface maps
were utilized to visualize ligand portals and the internal binding cavity of native and 4-HNE adducted L-FABP. Areas colored brown indicate more
lipophilic sites of the protein, while the blue indicates more hydrophilic portions. Both apo (A) and holo (B) L-FABP have a well-defined binding area
within the protein cavity. Upon 4-HNE adduction, it is clear that both the integrity and size of the binding pocket diminishes in the ‘‘open chain’’ apo
(C), holo (D), and the HA structures (E,F).
doi:10.1371/journal.pone.0038459.g007
Figure 8. New portals for ligand entry/exit are observed following aldehyde adduction. (B) In the apo state, a new portal appears when 4-
HNE is bound below portal 2, P4. In the holo state, a different portal appears slightly south of portal 1, P5, in 4-HNE modified L-FABP (D) and in the 4-
HNE hemiacetal (F). Asterisks denote the presence of a portal: Yellow = Portal 2; Blue = Portal 1; Red = P4, P5. Linoleic acid bound in site 2 is also
shown in holo-L-FABP: native = orange, 4-HNE HA = green. The lipophilic map is shown on the right: brown (hydrophobic) to blue scale
(hydrophillic) with units given in kcal/mol.
doi:10.1371/journal.pone.0038459.g008
4-HNE Alters L-FABP Functional Dynamics
PLoS ONE | www.plosone.org 14 June 2012 | Volume 7 | Issue 6 | e38459perturbations in lipid trafficking and metabolism observed with
early stages of ALD.
Supporting Information
Figure S1 4-HNE adducts are identified on peptides
AIGLPEDLQK31HNEGK, GVSEIVH43HNEEGK, and LTI-
TYGPK57HNEVVR. All of these protein adducts were identified
to react with 4-HNE through a MA-type reaction. Identified b/y
ions are labeled within the spectrum and shown along the peptide
backbone above the spectrum. The parent ion of the MS/MS
fragment is shown as an inset in the upper right corner of the
spectrum.
(TIF)
Figure S2 Schiff base adducts were identified on
peptides LTITYGPK57HNEVVR (A and B) and
MNFSGK6HNEYQLQSQENFEPFMK (C and D) of L-FABP.
Spectra are shown for the same peptide, with varying degrees of
methionine oxidation. Identified b/y ions are labeled within the
spectrum and shown along the peptide backbone above the
spectrum. The parent ion of the MS/MS fragment is shown as an
inset in the upper right corner of the spectrum.
(TIF)
Figure S3 Alpha carbons of reference residues that
surround binding portals 1 and 2 were mapped to
visualize changes in ligand accessibility following 4-HNE
adduction. Native apo (A and D) and holo (G and J); 4-HNE
adducted apo (B and E) and holo (H and K), and 4-HNE HA apo
(C and F) and holo (I and L).
(TIF)
Table S1 4-HNE immunopositive proteins picked and
identified in cytosolic fractions of mice chronically fed
with ethanol.
(DOC)
Acknowledgments
We thank Drs. Philip Reigan and Donald Backos in the Molecular
Modeling Core and Joe Gomez in the School of Pharmacy Mass
Spectrometry Core at the University of Colorado Anschutz Medical
Campus for their expertise and time. We would also like to thank
Dr. Brooke Hirsch in the Biophysics Core at University of Colorado
Anschutz Medical Campus for allowing us to use instrumentation and the
University of Colorado Cancer Center for verifying all DNA sequences.
We also thank Dr. Qiang You and Brittany Murphy for help with the RT-
PCR experiments.
Author Contributions
Conceived and designed the experiments: RS CS DP. Performed the
experiments: RS KF JG PR. Analyzed the data: RS PR MM. Wrote the
paper: RS.
References
1. Seitz HK, Lieber CS, Stickel F, Salaspuro M, Schlemmer HP, et al. (2005)
Alcoholic liver disease: from pathophysiology to therapy. Alcohol Clin Exp Res
29: 1276–1281.
2. Beier JI, Arteel GE, McClain CJ (2011) Advances in alcoholic liver disease. Curr
Gastroenterol Rep 13: 56–64.
3. Ramaiah S, Rivera C, Arteel G (2004) Early-phase alcoholic liver disease: an
update on animal models, pathology, and pathogenesis. Int J Toxicol 23:
217–231.
4. Conde de la Rosa L, Moshage H, Nieto N (2008) [Hepatocyte oxidant stress and
alcoholic liver disease]. Rev Esp Enferm Dig 100: 156–163.
5. Arteel GE (2003) Oxidants and antioxidants in alcohol-induced liver disease.
Gastroenterology 124: 778–790.
6. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-
hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med
11: 81–128.
7. Doorn JA, Petersen DR (2002) Covalent modification of amino acid
nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-
oxo-2-nonenal. Chem Res Toxicol 15: 1445–1450.
8. Comporti M (1998) Lipid peroxidation and biogenic aldehydes: from the
identification of 4-hydroxynonenal to further achievements in biopathology.
Free Radic Res 28: 623–635.
9. Sayre LM, Lin D, Yuan Q, Zhu X, Tang X (2006) Protein adducts generated
from products of lipid oxidation: focus on HNE and one. Drug Metab Rev 38:
651–675.
10. Uchida K, Stadtman ER (1992) Modification of histidine residues in proteins by
reaction with 4-hydroxynonenal. Proc Natl Acad Sci U S A 89: 4544–4548.
11. Petersen DR, Doorn JA (2004) Reactions of 4-hydroxynonenal with proteins and
cellular targets. Free Radic Biol Med 37: 937–945.
12. Toyokuni S, Yamada S, Kashima M, Ihara Y, Yamada Y, et al. (2000) Serum 4-
hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes
mellitus. Antioxid Redox Signal 2: 681–685.
13. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, et al. (1997) In situ
detection of lipid peroxidation by-products in chronic liver diseases. Hepatology
26: 135–142.
14. Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in
metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:
489–503.
15. Smathers RL, Petersen DR (2011) The human fatty acid-binding protein family:
evolutionary divergences and functions. Hum Genomics 5: 170–191.
16. Thompson J, Reese-Wagoner A, Banaszak L (1999) Liver fatty acid binding
protein: species variation and the accommodation of different ligands. Biochim
Biophys Acta 1441: 117–130.
17. Atshaves BP, Martin GG, Hostetler HA, McIntosh AL, Kier AB, et al. (2010)
Liver fatty acid-binding protein and obesity. J Nutr Biochem 21: 1015–1032.
18. Smathers RL, Galligan JJ, Stewart BJ, Petersen DR (2011) Overview of lipid
peroxidation products and hepatic protein modification in alcoholic liver
disease. Chem Biol Interact 192: 107–112.
19. Galligan JJ, Fritz KS, Tipney H, Smathers RL, Roede JR, et al. (2011) Profiling
impaired hepatic endoplasmic reticulum glycosylation as a consequence of
ethanol ingestion. J Proteome Res 10: 1837–1847.
20. Roede JR, Stewart BJ, Petersen DR (2008) Decreased expression of
peroxiredoxin 6 in a mouse model of ethanol consumption. Free Radic Biol
Med 45: 1551–1558.
21. Carbone DL, Doorn JA, Kiebler Z, Sampey BP, Petersen DR (2004) Inhibition
of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem Res
Toxicol 17: 1459–1467.
22. Little RG, 2nd, Petersen DR (1983) Subcellular distribution and kinetic
parameters of HS mouse liver aldehyde dehydrogenase. Comp Biochem
Physiol C 74: 271–279.
23. Smathers RL, Galligan JJ, Stewart BJ, Petersen DR Overview of lipid
peroxidation products and hepatic protein modification in alcoholic liver
disease. Chem Biol Interact 192: 107–112.
24. Clugston RD, Jiang H, Lee MX, Piantedosi R, Yuen JJ, et al. (2011) Altered
hepatic lipid metabolism in C57BL/6 mice fed alcohol: A targeted lipidomic and
gene expression study. J Lipid Res.
25. You Q, Cheng L, Reilly TP, Wegmann D, Ju C (2006) Role of neutrophils in a
mouse model of halothane-induced liver injury. Hepatology 44: 1421–1431.
26. Cham BE, Knowles BR (1976) A solvent system for delipidation of plasma or
serum without protein precipitation. J Lipid Res 17: 176–181.
27. Ockner RK, Manning JA, Kane JP (1982) Fatty acid binding protein. Isolation
from rat liver, characterization, and immunochemical quantification. J Biol
Chem 257: 7872–7878.
28. Kane CD, Bernlohr DA (1996) A simple assay for intracellular lipid-binding
proteins using displacement of 1-anilinonaphthalene 8-sulfonic acid. Anal
Biochem 233: 197–204.
29. Moller MaDA (2002) Study of Protein-Ligand Binding by Fluorescence
Biochemistry and Molecular Biology Education 30: 309–312.
30. Chuang S, Velkov T, Horne J, Porter CJ, Scanlon MJ (2008) Characterization
of the drug binding specificity of rat liver fatty acid binding protein. J Med Chem
51: 3755–3764.
31. Schulenberg-Schell H, Schafer P, Keuper HJ, Stanislawski B, Hoffmann E, et al.
(1988) Interactions of fatty acids with neutral fatty-acid-binding protein from
bovine liver. Eur J Biochem 170: 565–574.
32. Wang W (2005) Protein aggregation and its inhibition in biopharmaceutics.
Int J Pharm 289: 1–30.
33. Thompson J, Winter N, Terwey D, Bratt J, Banaszak L (1997) The crystal
structure of the liver fatty acid-binding protein. A complex with two bound
oleates. J Biol Chem 272: 7140–7150.
34. Shen MY, Sali A (2006) Statistical potential for assessment and prediction of
protein structures. Protein Sci 15: 2507–2524.
35. Koska J, Spassov VZ, Maynard AJ, Yan L, Austin N, et al. (2008) Fully
automated molecular mechanics based induced fit protein-ligand docking
method. J Chem Inf Model 48: 1965–1973.
4-HNE Alters L-FABP Functional Dynamics
PLoS ONE | www.plosone.org 15 June 2012 | Volume 7 | Issue 6 | e3845936. Zou XQ, Sun YX, Kuntz ID (1999) Inclusion of solvation in ligand binding free
energy calculations using the generalized-born model. Journal of the American
Chemical Society 121: 8033–8043.
37. Sampey BP, Stewart BJ, Petersen DR (2007) Ethanol-induced modulation of
hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydro-
xynonenal. J Biol Chem 282: 1925–1937.
38. Richieri GV, Ogata RT, Kleinfeld AM (1996) Thermodynamic and kinetic
properties of fatty acid interactions with rat liver fatty acid-binding protein. J Biol
Chem 271: 31068–31074.
39. He Y, Yang X, Wang H, Estephan R, Francis F, et al. (2007) Solution-state
molecular structure of apo and oleate-liganded liver fatty acid-binding protein.
Biochemistry 46: 12543–12556.
40. Marnett LJ, Riggins JN, West JD (2003) Endogenous generation of reactive
oxidants and electrophiles and their reactions with DNA and protein. J Clin
Invest 111: 583–593.
41. Zimmerman AW, Veerkamp JH (2002) New insights into the structure and
function of fatty acid-binding proteins. Cell Mol Life Sci 59: 1096–1116.
42. LoPachin RM, Gavin T, Petersen DR, Barber DS (2009) Molecular
mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets
and adduct formation. Chem Res Toxicol 22: 1499–1508.
43. Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative
stress. Prog Lipid Res 42: 318–343.
44. Poli G, Biasi F, Leonarduzzi G (2008) 4-Hydroxynonenal-protein adducts: A
reliable biomarker of lipid oxidation in liver diseases. Mol Aspects Med 29:
67–71.
45. Poli G, Schaur RJ, Siems WG, Leonarduzzi G (2008) 4-hydroxynonenal: a
membrane lipid oxidation product of medicinal interest. Med Res Rev 28:
569–631.
46. Stewart BJ, Doorn JA, Petersen DR (2007) Residue-specific adduction of tubulin
by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits
polymerization. Chem Res Toxicol 20: 1111–1119.
47. Backos DS, Fritz KS, Roede JR, Petersen DR, Franklin CC (2011)
Posttranslational modification and regulation of glutamate-cysteine ligase by
the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal. Free Radic Biol Med
50: 14–26.
48. Fritz KS, Galligan JJ, Smathers RL, Roede JR, Shearn CT, et al. (2011) 4-
Hydroxynonenal inhibits SIRT3 via thiol-specific modification. Chem Res
Toxicol 24: 651–662.
49. Roede JR, Carbone DL, Doorn JA, Kirichenko OV, Reigan P, et al. (2008) In
vitro and in silico characterization of peroxiredoxin 6 modified by 4-
hydroxynonenal and 4-oxononenal. Chem Res Toxicol 21: 2289–2299.
50. Carbone DL, Doorn JA, Kiebler Z, Petersen DR (2005) Cysteine modification
by lipid peroxidation products inhibits protein disulfide isomerase. Chem Res
Toxicol 18: 1324–1331.
51. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers
of oxidative damage in human disease. Clin Chem 52: 601–623.
52. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, et al. (2006) Protein
carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10:
389–406.
53. Carbone DL, Doorn JA, Kiebler Z, Ickes BR, Petersen DR (2005) Modification
of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic
alcoholic liver disease. J Pharmacol Exp Ther 315: 8–15.
54. Newton BW, Russell WK, Russell DH, Ramaiah SK, Jayaraman A (2009) Liver
proteome analysis in a rodent model of alcoholic steatosis. J Proteome Res 8:
1663–1671.
55. Purohit V, Russo D, Coates PM (2004) Role of fatty liver, dietary fatty acid
supplements, and obesity in the progression of alcoholic liver disease:
introduction and summary of the symposium. Alcohol 34: 3–8.
56. Clugston RD, Jiang H, Lee MX, Piantedosi R, Yuen JJ, et al. (2021–2031) .
57. Pignon JP, Bailey NC, Baraona E, Lieber CS (1987) Fatty acid-binding protein:
a major contributor to the ethanol-induced increase in liver cytosolic proteins in
the rat. Hepatology 7: 865–871.
58. Lu Y, Zhuge J, Wang X, Bai J, Cederbaum AI (2008) Cytochrome P450 2E1
contributes to ethanol-induced fatty liver in mice. Hepatology 47: 1483–1494.
59. Bennaars-Eiden A, Higgins L, Hertzel AV, Kapphahn RJ, Ferrington DA, et al.
(2002) Covalent modification of epithelial fatty acid-binding protein by 4-
hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology.
J Biol Chem 277: 50693–50702.
60. Grimsrud PA, Picklo MJ, Sr, Griffin TJ, Bernlohr DA (2007) Carbonylation of
adipose proteins in obesity and insulin resistance: identification of adipocyte fatty
acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell
Proteomics 6: 624–637.
61. Storch J, McDermott L (2009) Structural and functional analysis of fatty acid-
binding proteins. J Lipid Res 50 Suppl. pp S126–131.
62. Long D, Mu Y, Yang D (2009) Molecular dynamics simulation of ligand
dissociation from liver fatty acid binding protein. PLoS One 4: e6081.
63. Fritz KS, Petersen DR (2011) Exploring the biology of lipid peroxidation-
derived protein carbonylation. Chem Res Toxicol 24: 1411–1419.
64. Codreanu SG, Zhang B, Sobecki SM, Billheimer DD, Liebler DC (2009) Global
analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol
Cell Proteomics 8: 670–680.
65. Galligan JJ, Smathers RL, Fritz KS, Epperson E, Hunter LE, et al. (2012)
Protein Carbonylation in a Murine Model for Early Alcoholic Liver Disease.
Chem Res Toxicol.
66. Martin GG, Atshaves BP, McIntosh AL, Mackie JT, Kier AB, et al. (2005) Liver
fatty-acid-binding protein (L-FABP) gene ablation alters liver bile acid
metabolism in male mice. Biochem J 391: 549–560.
67. Martin GG, Danneberg H, Kumar LS, Atshaves BP, Erol E, et al. (2003)
Decreased liver fatty acid binding capacity and altered liver lipid distribution in
mice lacking the liver fatty acid-binding protein gene. J Biol Chem 278:
21429–21438.
68. Martin GG, Huang H, Atshaves BP, Binas B, Schroeder F (2003) Ablation of the
liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity
and alters fatty acyl CoA pool distribution in mouse liver. Biochemistry 42:
11520–11532.
69. McIntosh AL, Atshaves BP, Hostetler HA, Huang H, Davis J, et al. (2009) Liver
type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand
distribution and peroxisome proliferator-activated receptor-alpha activity in
cultured primary hepatocytes. Arch Biochem Biophys 485: 160–173.
70. Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, et al. (2008)
Role of fatty acid binding proteins and long chain fatty acids in modulating
nuclear receptors and gene transcription. Lipids 43: 1–17.
71. Benedetti A, Comporti M, Fulceri R, Esterbauer H (1984) Cytotoxic aldehydes
originating from the peroxidation of liver microsomal lipids. Identification of
4,5-dihydroxydecenal. Biochim Biophys Acta 792: 172–181.
72. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, et al. (1995)
Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:
620–630.
73. Zimmerman AW, van Moerkerk HT, Veerkamp JH (2001) Ligand specificity
and conformational stability of human fatty acid-binding proteins. Int J Biochem
Cell Biol 33: 865–876.
74. Richieri GV, Ogata RT, Zimmerman AW, Veerkamp JH, Kleinfeld AM (2000)
Fatty acid binding proteins from different tissues show distinct patterns of fatty
acid interactions. Biochemistry 39: 7197–7204.
75. Doorn JA, Petersen DR (2003) Covalent adduction of nucleophilic amino acids
by 4-hydroxynonenal and 4-oxononenal. Chem Biol Interact 143–144: 93–100.
76. Lopachin RM, Gavin T, Decaprio A, Barber DS (2012) Application of the Hard
and Soft, Acids and Bases (HSAB) Theory to Toxicant-Target Interactions.
Chem Res Toxicol 25: 239–251.
77. Donohue TM, Jr., Osna NA (2003) Intracellular proteolytic systems in alcohol-
induced tissue injury. Alcohol Res Health 27: 317–324.
78. Palleros DR, Shi L, Reid KL, Fink AL (1994) hsp70-protein complexes.
Complex stability and conformation of bound substrate protein. J Biol Chem
269: 13107–13114.
79. Dormann P, Borchers T, Korf U, Hojrup P, Roepstorff P, et al. (1993) Amino
acid exchange and covalent modification by cysteine and glutathione explain
isoforms of fatty acid-binding protein occurring in bovine liver. J Biol Chem 268:
16286–16292.
80. Sato T, Baba K, Takahashi Y, Uchiumi T, Odani S (1996) Rat liver fatty acid-
binding protein: identification of a molecular species having a mixed disulfide
with cysteine at cysteine-69 and enhanced protease susceptibility. J Biochem
120: 908–914.
81. Herr FM, Matarese V, Bernlohr DA, Storch J (1995) Surface lysine residues
modulate the collisional transfer of fatty acid from adipocyte fatty acid binding
protein to membranes. Biochemistry 34: 11840–11845.
82. Kim HK, Storch J (1992) Free fatty acid transfer from rat liver fatty acid-binding
protein to phospholipid vesicles. Effect of ligand and solution properties. J Biol
Chem 267: 77–82.
4-HNE Alters L-FABP Functional Dynamics
PLoS ONE | www.plosone.org 16 June 2012 | Volume 7 | Issue 6 | e38459